mgc(3Me)FDA_product_DataBase

Bioactivity	mgc(3Me)FDA is fluorescein diacetate (FDA) modified with a cell-permeable myrGC3Me motif. mgc(3Me)FDA can enter cells and be converted into fluorescently active mgc(3Me)FL (HY-D2301) within the cells. mgc(3Me)FDA is subcellularly localized in the Golgi apparatus and is a visualized Golgi probe[1].
Invitro	mgc(3Me)FDA (10 μM; 10 min) 处理 HeLa 细胞后，可与细胞核周的高尔基体共定位并显示出绿色荧光[1]。mgc(3Me)FDA (2.5 μM; 30-270 min) 在受 Brefeldin A (HY-16592) 诱导的 HeLa 活细胞中，能够可视化高尔基体裂解时的形态的动态变化[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> mgc(3Me)FDA 相关抗体: Immunofluorescence[1] Cell Line:
CAS	2763442-01-7
Formula	C59H80N6O15S
Molar Mass	1145.36
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Sawada S, et al. Palmitoylation-Dependent Small-Molecule Fluorescent Probes for Live-Cell Golgi Imaging. ACS Chem Biol. 2023 May 19;18(5):1047-1053.

PeptideDB